| Kayla Jo Madler, DC | |
|
315 S Main St #101, Burns, WY 82053-0333 | |
| (307) 547-3330 | |
| (307) 547-3339 |
| Full Name | Kayla Jo Madler |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 20 Years |
| Location | 315 S Main St #101, Burns, Wyoming |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922193424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 718 (Wyoming) | Primary |
| Provider Name | Chiropractic Sports & Wellness Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114216082 PECOS PAC ID: 0547448003 Enrollment ID: O20110705000055 |
News Archive
Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency.
Mayo Clinic researchers recently released study data showing children who lived near major highway or railroad intersections have higher diagnoses of asthma.
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
Tamara Ritchie lost 25 pounds in 12 weeks without breaking a sweat. She was just following doctors' orders.
The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
› Verified 6 days ago
| Provider Name | Your Family Chiropractic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437310794 PECOS PAC ID: 2961562491 Enrollment ID: O20200512002057 |
News Archive
Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency.
Mayo Clinic researchers recently released study data showing children who lived near major highway or railroad intersections have higher diagnoses of asthma.
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
Tamara Ritchie lost 25 pounds in 12 weeks without breaking a sweat. She was just following doctors' orders.
The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kayla Jo Madler, DC Po Box 333, Burns, WY 82053-0333 Ph: (307) 547-3330 | Kayla Jo Madler, DC 315 S Main St #101, Burns, WY 82053-0333 Ph: (307) 547-3330 |
News Archive
Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency.
Mayo Clinic researchers recently released study data showing children who lived near major highway or railroad intersections have higher diagnoses of asthma.
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
Tamara Ritchie lost 25 pounds in 12 weeks without breaking a sweat. She was just following doctors' orders.
The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
› Verified 6 days ago
Your Family Health Care Chiropractor Medicare: Medicare Enrolled Practice Location: 315 S Main St #101, Burns, WY 82053 Phone: 307-547-3330 Fax: 307-547-3339 |